Vaccinex (VCNX) Stock Price
Vaccinex Price
Over the last 9 years Vaccinex grew revenue by 23.4% annually, reaching 2.10 M USD. For Vaccinex, the net margin of -251.1% is up versus -2,486.7% a few years ago.
Vaccinex stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Vaccinex business model & stock analysis
Frequently asked questions about Vaccinex
7 analysts currently rate the Vaccinex stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Vaccinex share trades at 0.89 EUR (1.00 USD).
The Vaccinex share (VCNX) is listed on 1 stock exchanges, including: NASDAQ (VCNX).
The revenue cannot currently be calculated for Vaccinex.
The profit cannot currently be calculated for Vaccinex.
The P/E ratio cannot be calculated for Vaccinex at the moment.
The P/S cannot be calculated for Vaccinex currently.
The Eulerpool Quality Score for Vaccinex is 3/10.
The ISIN of Vaccinex is US9186403013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Vaccinex is A2N30M. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Vaccinex is VCNX. The ticker symbol is used to trade Vaccinex shares on the stock exchange.
Vaccinex stock
Vaccinex Peer Group
Vaccinex Ticker
All fundamentals and in-depth analysis of Vaccinex
Our stock analysis for Vaccinex stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vaccinex. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.